CARMEN Martin Carreras-Presas

Prof. CARMEN Martin Carreras-Presas

Universidad Europea, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2016 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
KKKarolina Elżbieta Kaczor-Urbanowicz
Karolina Elżbieta Kaczor-Urbanowicz
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
KAKatri Aro
Katri Aro
MTMichael Tu
Michael Tu
Franklin Garcia-GodoyFranklin Garcia-Godoy
Franklin Garcia-Godoy
DWDavid Tw Wong
David Tw Wong
In this review, we provide an update on the current and future applications of saliva for diagnostic purposes. There are many advantages of using saliva as a biofluid. Its collection is fast, easy, inexpensive, and non-invasive. In addition, saliva, as a “mirror of the body,” can reflect the physiological and pathological state of the body. Therefore, it serves as a diagnostic and monitoring tool in many fields of science such as medicine, dentistry, and pharmacotherapy. Introduced in 2008, the term “Salivaomics” aimed to highlight the rapid development of knowledge about various “omics” constituents of saliva, including: proteome, transcriptome, micro-RNA, metabolome, and microbiome. In the last few years, researchers have developed new technologies and validated a wide range of salivary biomarkers that will soon make the use of saliva a clinical reality. However, a great need still exists for convenient and accurate point-of-care devices that can serve as a non-invasive diagnostic tool. In addition, there is an urgent need to decipher the scientific rationale and mechanisms that convey systemic diseases to saliva. Another promising technology called liquid biopsy enables detection of circulating tumor cells (CTCs) and fragments of tumor DNA in saliva, thus enabling non-invasive early detection of various cancers. The newly developed technology—electric field-induced release and measurement (EFIRM) provides near perfect detection of actionable mutations in lung cancer patients. These recent advances widened the salivary diagnostic approach from the oral cavity to the whole physiological system, and thus point towards a promising future of salivary diagnostics for personalized individual medicine applications including clinical decisions and post-treatment outcome predictions. Impact statement: The purpose of this mini-review is to make an update about the present and future applications of saliva as a diagnostic biofluid in many fields of science such as dentistry, medicine and pharmacotherapy. Using saliva as a fluid for diagnostic purposes would be a huge breakthrough for both patients and healthcare providers since saliva collection is easy, non-invasive and inexpensive. We will go through the current main diagnostic applications of saliva, and provide a highlight on the emerging, newly developing technologies and tools for cancer screening, detection and monitoring.

29 May 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
JSJuan Amaro Sánchez
Juan Amaro Sánchez
ALAntonio Francisco López‐Sánchez
Antonio Francisco López‐Sánchez
ESENRIC SALAS
ENRIC SALAS
MPMaria Luisa Somacarrera Pérez
Maria Luisa Somacarrera Pérez

15 April 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJesus Rodriguez-Molinero
Jesus Rodriguez-Molinero
BMBlanca del Carmen Migueláñez Medrán
Blanca del Carmen Migueláñez Medrán
CGCristina Puente Gutiérrez
Cristina Puente Gutiérrez
EDEsther Delgado-Somolinos
Esther Delgado-Somolinos
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
ALAntonio Lopez
Antonio Lopez
Oral cancer, included within head and neck cancer, is the sixth most common malignant neoplasm in the world. The main etiological factors are tobacco and alcohol, although currently, diet is considered an important determinant for its development. Several dietary nutrients have specific mechanisms of action, contributing to both protection against cancer and increasing the risk for development, growth, and spread. Foods such as fruits, vegetables, curcumin, and green tea can reduce the risk of oral cancer, while the so-called pro-inflammatory diet, rich in red meat and fried foods, can enhance the risk of occurrence. Dietary factors with a protective effect show different mechanisms that complement and overlap with antioxidant, anti-inflammatory, anti-angiogenic, and anti-proliferative effects. The main limitation of in vivo studies is the complexity of isolating the effects related to each one of the nutrients and the relationship with other possible etiological mechanisms. On the contrary, in vitro studies allow determining the specific mechanisms of action of some of the dietary compounds. In conclusion, and despite research limitations, the beneficial effects of a diet rich in vegetables and fruits are attributed to different micronutrients that are also found in fish and animal products. These compounds show antioxidant, anti-inflammatory, anti-angiogenic, and anti-proliferative properties that have a preventive role in the development of oral and other types of cancer.

13 November 2016 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
KKKarolina Elżbieta Kaczor‐Urbanowicz
Karolina Elżbieta Kaczor‐Urbanowicz
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
TKTadeusz Kaczor
Tadeusz Kaczor
MTMichael Tu
Michael Tu
FWFang Wei
Fang Wei
David WongDavid Wong
David Wong
Salivary diagnostics has great potential to be used in the early detection and prevention of many cancerous diseases. If implemented with rigour and efficiency, it can result in improving patient survival times and achieving earlier diagnosis of disease. Recently, extraordinary efforts have been taken to develop non‐invasive technologies that can be applied without complicated and expensive procedures. Saliva is a biofluid that has demonstrated excellent properties and can be used as a diagnostic fluid, since many of the biomarkers suggested for cancers can also be found in whole saliva, apart from blood or other body fluids. The currently accepted gold standard methods for biomarker development include chromatography, mass spectometry, gel electrophoresis, microarrays and polymerase chain reaction‐based quantification. However, salivary diagnostics is a flourishing field with the rapid development of novel technologies associated with point‐of‐care diagnostics, RNA sequencing, electrochemical detection and liquid biopsy. Those technologies will help introduce population‐based screening programs, thus enabling early detection, prognosis assessment and disease monitoring. The purpose of this review is to give a comprehensive update on the emerging diagnostic technologies and tools for the early detection of cancerous diseases based on saliva.

CCCintia Chamorro
Cintia Chamorro
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
ASAdriana Sanz-Marchena
Adriana Sanz-Marchena
AFAlmudena Rodriguez Fernandez
Almudena Rodriguez Fernandez
JSJosé María Suárez-Quintanilla
José María Suárez-Quintanilla
Mario Pérez-SayánsMario Pérez-Sayáns
Mario Pérez-Sayáns
Objectives: The COVID-19 (SARS-CoV-2) pandemic is an ongoing public health challenge, also for the dentistry community. The main objective of this paper was to determine the economic and health-care impact of COVID-19 on dentists in the Autonomous Region of Galicia (Spain). Methods: This was a descriptive observational study in which the data was collected by means of a self-administered survey (from 1 April 2020 to 30 April 2020). Results: A total of 400 dentists from Galicia responded to the survey. Only 12.3% of the participants could obtain personal protective equipment (PPE) including FFP2 masks. Of the male respondents, 33.1% suffered losses >€15,000 compared to 19.4% of female respondents (OR = 3.121, p < 0.001). Economic losses seem to have contributed to the applications for economic help as 29.5% of the respondents who applied for this measure recorded losses in excess of €15,000 (p = 0.03). Patients complained more about the fact that only emergency care was available during the State of Alarm, in dental surgeries that do not work with insurance companies or franchises. Only 4 professionals tested positive, 50% of whom worked exclusively in private practice and the other 50% who practised in both private and public surgeries. Dentists who practise in the public sector saw more urgent patients per week than those practising in private surgeries (p = 0.013). Conclusions: The COVID-19 pandemic has had economic repercussions in dentistry as only urgent treatment was available during the State of Alarm. These repercussions seem to be higher in male participants, as the majority of the participants have revealed higher economic losses than females. The level of assistance has also been affected, reducing the number of treated patients, although this quantity has been different in private and public surgeries. By presenting these findings we look to highlight the role that dentists play in society in treating dental emergencies in our surgeries, and this must be recognised and addressed by the relevant authorities, who must provide PPEs as a priority to this group as well as providing special economic aid in accordance with the losses incurred by the sector.

12 January 2025 in Nutrients
Verified
Journal Article
Open access
ERIKA MELÉNDEZ-OLIVAERIKA MELÉNDEZ-OLIVA
ERIKA MELÉNDEZ-OLIVA
Oliver Martínez PozasOliver Martínez Pozas
Oliver Martínez Pozas
Pierluigi SinattiPierluigi Sinatti
Pierluigi Sinatti
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
JZJuan Nicolás Cuenca Zaldívar
Juan Nicolás Cuenca Zaldívar
Eleuterio A. Sánchez RomeroEleuterio A. Sánchez Romero
Eleuterio A. Sánchez Romero
Introduction: Osteoarthritis (OA) is the most prevalent form of arthritis and affects over 528 million people worldwide. Degenerative joint disease involves cartilage degradation, subchondral bone remodeling, and synovial inflammation, leading to chronic pain, stiffness, and impaired joint function. Initially regarded as a “wear and tear” condition associated with aging and mechanical stress, OA is now recognized as a multifaceted disease influenced by systemic factors such as metabolic syndrome, obesity, and chronic low-grade inflammation. Recent studies have focused on the gut-joint axis to investigate how the gut microbiome modulates inflammation and pain in OA. Materials and Methods: A systematic review was conducted following the PRISMA guidelines and was registered with PROSPERO (CRD42024556265). This review included studies involving adults with symptomatic OA and analyzed the relationship between the gut microbiome and OA-related pain. Randomized and non-randomized clinical trials, case reports, editorials, and pilot studies were excluded. Searches were performed in PubMed, Cochrane Library, and Web of Science without publication date restrictions, and filtered for “observational studies”. The study selection and data extraction were performed by two independent researchers, and the risk of bias was assessed using appropriate tools. Results: Five observational studies were included in the systematic review, and three were included in the meta-analysis. Two studies reported an association between different tryptophan metabolites and pain levels in patients with OA. Two other studies demonstrated a correlation between lipopolysaccharide levels and pain in OA. A fifth study confirmed the relationship between Streptococcus relative abundance of Streptococcus spp. and knee pain. These results were not supported by a meta-analysis, which found no significant association between the presence of pain in OA and the presence of bacilli of the genus Streptococcus or plasma markers of the tryptophan pathway. Conclusions: Current evidence indicates a potential link between gut microbiome dysbiosis and OA-related pain. However, methodological limitations preclude definitive conclusions. Further research using advanced techniques and larger cohorts is needed to validate and extend these findings and elucidate the underlying mechanisms. Targeted manipulation of the gut microbiome may be a valuable strategy for pain management in OA patients.